205 related articles for article (PubMed ID: 1660950)
1. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
Kiers L; Altermatt HJ; Lennon VA
Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
[TBL] [Abstract][Full Text] [Related]
2. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity.
Chan KH; Vernino S; Lennon VA
Ann Neurol; 2001 Sep; 50(3):301-11. PubMed ID: 11558786
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells.
Altermatt HJ; Rodriguez M; Scheithauer BW; Lennon VA
Lab Invest; 1991 Oct; 65(4):412-20. PubMed ID: 1921331
[TBL] [Abstract][Full Text] [Related]
4. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.
Galanis E; Frytak S; Rowland KM; Sloan JA; Lennon VA
Cancer Immunol Immunother; 1999; 48(2-3):85-90. PubMed ID: 10414461
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
Lucchinetti CF; Kimmel DW; Lennon VA
Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
[TBL] [Abstract][Full Text] [Related]
6. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
7. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
8. Anti-neuronal antibodies in paraneoplastic neurological disorders with small-cell lung carcinoma.
Moll JW; Henzen-Logmans SC; Vecht CJ
Clin Neurol Neurosurg; 1990; 92(3):223-8. PubMed ID: 2171829
[TBL] [Abstract][Full Text] [Related]
9. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
10. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma.
Saiz A; Dalmau J; Butler MH; Chen Q; Delattre JY; De Camilli P; Graus F
J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):214-7. PubMed ID: 10071102
[TBL] [Abstract][Full Text] [Related]
11. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.
Pittock SJ; Lucchinetti CF; Lennon VA
Ann Neurol; 2003 May; 53(5):580-7. PubMed ID: 12730991
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in neurological paraneoplastic diseases.
Lövblad KO; Boucraut J; Lehmann HP; Stahel R; Regli F; Steck AJ
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):3-7. PubMed ID: 7533934
[TBL] [Abstract][Full Text] [Related]
13. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
14. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ
J Neuroimmunol; 2019 Jan; 326():14-18. PubMed ID: 30445363
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
Dalmau J; Graus F; Cheung NK; Rosenblum MK; Ho A; Cañete A; Delattre JY; Thompson SJ; Posner JB
Cancer; 1995 Jan; 75(1):99-109. PubMed ID: 7804984
[TBL] [Abstract][Full Text] [Related]
16. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
17. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
20. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
